<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 /home/lopez/grobid/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Left ventricular structure and remodeling in patients with COPD</title>
			</titleStmt>
			<publicationStmt>
				<publisher>Dove Medical Press Ltd.</publisher>
				<availability status="unknown"><p>Copyright Dove Medical Press Ltd.</p>
				</availability>
				<date type="published" when="2016-05-13">13 May 2016</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author role="corresp">
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Giovanna</forename><surname>Pel√†</surname></persName>
							<email>giovanna.pela@unipr.it</email>
							<affiliation key="aff0">
								<orgName type="department">Department of Clinical and experimental Medicine</orgName>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mauro</forename><surname>Li Calzi</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Clinical and experimental Medicine</orgName>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Silvana</forename><surname>Pinelli</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Clinical and experimental Medicine</orgName>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Roberta</forename><surname>Andreoli</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Clinical and experimental Medicine</orgName>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Nicola</forename><surname>Sverzellati</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Department of surgery</orgName>
								<orgName type="institution" key="instit1">University Medical school</orgName>
								<orgName type="institution" key="instit2">University hospital Parma</orgName>
								<address>
									<settlement>Parma</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Giuseppina</forename><surname>Bertorelli</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Clinical and experimental Medicine</orgName>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Matteo</forename><surname>Goldoni</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Clinical and experimental Medicine</orgName>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Alfredo</forename><forename type="middle">Antonio</forename><surname>Chetta</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Clinical and experimental Medicine</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff2">
								<orgName type="department">Department of Clinical and experimental Medicine, University Medical school and University hospital Parma</orgName>
								<address>
									<addrLine>Via gramsci 14</addrLine>
									<postCode>43100</postCode>
									<settlement>Parma</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Left ventricular structure and remodeling in patients with COPD</title>
					</analytic>
					<monogr>
						<title level="j" type="main">International Journal of Chronic Obstructive Pulmonary Disease</title>
						<title level="j" type="abbrev">COPD</title>
						<idno type="eISSN">1178-2005</idno>
						<imprint>
							<publisher>Dove Medical Press Ltd.</publisher>
							<biblScope unit="page">1015</biblScope>
							<date type="published" when="2016-05-13">13 May 2016</date>
						</imprint>
					</monogr>
					<idno type="DOI">10.2147/copd.s102831</idno>
					<idno type="PMID">27257378</idno>
					<idno type="PMCID">PMC4874631</idno>
					<ptr type="open-access" target="https://www.dovepress.com/getfile.php?fileID=30378" />
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.6.2-SNAPSHOT" ident="GROBID" when="2020-08-13T23:25+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>COPD</term>
					<term>Doppler tissue echocardiography</term>
					<term>left ventricular remodeling</term>
					<term>emphysema score</term>
					<term>right ventricular function</term>
					<term>left ventricular function</term>
				</keywords>
			</textClass>
			<abstract>
				<p>Background: Data on cardiac alterations such as left ventricular (LV) hypertrophy, diastolic dysfunction, and lower stroke volume in patients with COPD are discordant. In this study, we investigated whether early structural and functional cardiac changes occur in patients with COPD devoid of manifest cardiovascular disease, and we assessed their associations with clinical and functional features. Methods: Forty-nine patients with COPD belonging to all Global Initiative for Chronic Obstructive Lung Disease (GOLD) classes were enrolled and compared with 36 controls. All subjects underwent clinical history assessment, lung function testing, blood pressure measurement, electrocardiography, and conventional and Doppler tissue echocardiography. Patients were also subjected to computed tomography to quantify emphysema score. Results: Patients with COPD had lower LV cavity associated with a marked increase in relative wall thickness (RWT), suggesting concentric remodeling without significant changes in LV mass. RWT was significantly associated with ratio of the forced expiratory volume in 1 second to the forced vital capacity and emphysema score and was the only cardiac parameter that-after multivariate analysis-significantly correlated with COPD conditions in all individuals. Receiver operating characteristic curve analysis showed that RWT (with a cutoff point of 0.42) predicted the severity of COPD with 83% specificity and 56% sensitivity (area under the curve =0.69, 95% confidence interval =0.59-0.81). Patients with COPD showed right ventricular to be functional but no structural changes. Conclusion: Patients with COPD without evident cardiovascular disease exhibit significant changes in LV geometry, resulting in concentric remodeling. In all individuals, RWT was significantly and independently related to COPD. However, its prognostic role should be determined in future studies.</p>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p>COPD is a major cause of mortality and morbidity. <ref type="bibr" target="#b0">1</ref> Extrapulmonary alterations, notably cardiac complications such as cor pulmonale, can be frequently observed in patients with COPD. In addition, coronary artery disease and heart failure may play important roles in mortality and morbidity in patients with COPD. <ref type="bibr" target="#b1">2</ref> Cardiovascular complications might not only be related to CODP itself but could also be due to a chronic systemic inflammatory condition, in which heart and lungs are differentially involved. <ref type="bibr" target="#b2">3</ref> Interestingly, changes in left ventricle function and structure such as left ventricular hypertrophy (LVH), diastolic dysfunction, and reduction in cardiac chambers and stroke volume have been described but might not be exclusively due to COPD. <ref type="bibr" target="#b3">[4]</ref><ref type="bibr" target="#b4">[5]</ref><ref type="bibr" target="#b5">[6]</ref> The lower preload caused by hyperinflation may be responsible for reduced left ventricular (LV) and right ventricular (RV) dimensions <ref type="bibr" target="#b3">4,</ref><ref type="bibr" target="#b4">5</ref> yet, a causal link between COPD and increased LV mass (LVM) <ref type="bibr" target="#b5">6</ref> has not been clearly established. Notably, these authors demonstrated a higher (30% versus 20% in controls) prevalence of LVH in normoxemic, normotensive patients with COPD, unrelated to forced expiratory volume in 1 second (FEV 1 ). In that study, relative wall thickness (RWT) value (an index of LV geometry) was similar between patients with COPD and controls. <ref type="bibr" target="#b5">6</ref> Chronic inflammation or pronounced activation of the renin-angiotensin-aldosterone system rather than airway obstruction could play major yet unclear roles.</p><p>It is worth noting that an echocardiographic-detected LVH is a strong predictor of cardiovascular events, especially when combined with concentric remodeling revealed by an increased RWT. <ref type="bibr" target="#b6">7,</ref><ref type="bibr" target="#b7">8</ref> Therefore, the assessment of LV geometry in patients with COPD could have relevant clinical impacts in terms of improving risk stratification for future cardiovascular events and augmenting prognosis. Thus far, this issue remains poorly investigated.</p><p>With the aim of characterizing cardiac remodeling in COPD, we selected patients from all Global Initiative for Chronic Obstructive Lung Disease (GOLD) classes, without history of cardiovascular disease, in order to exclude any confounding factor. The aims of the present work were twofold: 1) to evaluate the influence of different degrees of airway obstruction and lung hyperinflation on cardiac structures by analyzing both the right and the left ventricles. By evaluating LVM and RWT, we wanted to quantify LV remodeling and the prevalence of LVH in COPD and 2) to study the relationship between LV remodeling and morbidity of a COPD cohort.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Materials and methods study population</head><p>This study conforms to the Declaration of Helsinki and was approved by the Institutional Medical Ethics Committee of the University of Parma. All participants provided signed informed consent before recruitment (Protocol number 41361).</p><p>From 2008 to April 2015, we screened inpatients and outpatients of both sexes, affected by COPD ranging from mild-to-severe airflow obstruction, who were referred to the Lung Unit of the University Hospital of Parma. We selected only patients with COPD without previous diagnosis of cardiac disorders such as coronary artery disease, heart failure, significant valvular dysfunction, cardiomyopathies, chronic atrial fibrillation, or pacemaker and left bundle branch blocks. Patients with systemic arterial hypertension higher than stage I and insulin-dependent diabetes were also excluded. Patients with COPD were diagnosed and classified according to the GOLD criteria. As control group, we recruited sex-and agematched healthy subjects. Participants underwent spirometry and conventional and Doppler tissue echocardiography (DTE). Patients with COPD also underwent computed tomography (CT) scan.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Clinical examination</head><p>After recording their personal and parental medical history, study subjects underwent a physical examination and 12-lead resting electrocardiography; their blood pressure (BP) was determined in triplicate at 2-minute intervals (OMRON 705 IT, Omron, Kyoto, Japan). A normal office BP was defined as #140/90 mmHg. <ref type="bibr" target="#b8">9</ref> Body mass index (BMI) was calculated in kg/m 2 .</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Pulmonary function testing</head><p>Pulmonary function was measured by a flow-sensing spirometer connected to a computer for data analysis (Vmax 22 and 6200, Sensor Medics, Yorba Linda, CA, USA). Functional residual capacity was measured by body plethysmography (Vmax 22 and 6200, Sensor Medics). Total lung capacity (TLC) was calculated as the sum of functional residual capacity and linked inspiratory capacity. Residual volume was obtained by subtracting vital capacity (VC) from TLC. At least three measurements were taken for each spirometry and lung volume variable to ensure reproducibility. Forced vital capacity (FVC), FEV 1 , RV, and TLC were recorded and expressed as percent of predicted value. FEV 1 /FVC and residual volume/ TLC were also recorded and expressed as a ratio.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conventional and Doppler tissue echocardiography</head><p>M-mode, two-dimensional, and Doppler echocardiography were performed by one ultrasonography-experienced cardiologist (GP), using commercially available, multihertz sector, 2-4 MHz probe-equipped machines (Acuson Aspen, Siemens, Mountain View, CA, USA; Vivid S5, GE Healthcare, Wauwatosa, WI, USA). The examination was feasible for screening cardiac parameters in all the patients with COPD, despite concerns that echocardiography windows might be poor.</p><p>The interventricular septal (SWT) and posterior wall (PWT) thicknesses, systolic (ESD) and diastolic (EDD) LV diameters, absolute LVM, and indexed-to-body-surface-area (LVM/BSA) were calculated as previously described. <ref type="bibr" target="#b9">10,</ref><ref type="bibr" target="#b10">11</ref> LVH was defined as an LVM/BSA of .95 g/m 2 in women and .115 g/m 2 in men. <ref type="bibr" target="#b11">12</ref> RWT was calculated as (SWT + PWT)/EDD, using the 0.42 cutoff to define eccentric (#0.42) or concentric ($0.42) remodeling. <ref type="bibr" target="#b11">12</ref> Simpson's biplane rulebased end-diastolic (EDV) and systolic (ESV) volumes and ejection fraction (EF) were calculated, while fractional shortening (FS) was calculated as ([EDV -ESV]/EDV) √ó100.</p><p>The RV cavity was measured from the long-axis parasternal view to extract the transversal dimension at end-diastole and end-systole. Using the apical four-chamber view, the longitudinal axis (as the distance between the apex of the right ventricle and the center of the tricuspid ring) and the maximal transversal diameter, in the basal one-third of the RV inflow, were measured at the end-diastole. <ref type="bibr" target="#b11">12</ref> Pulmonary pressure was calculated directly by sampling the tricuspid insufficiency and indirectly by the acceleration time on pulmonary flow.</p><p>Mitral and tricuspidal inflow patterns were analyzed from apical four-chamber view and E-and A-wave, and their ratios were considered as peak flow velocity and time velocity integral, to evaluate the conventional diastolic function of both ventricles. From the same projection, DTE analysis was performed at the lateral site and posteroseptum of mitral annulus and lateral site of tricuspidal annulus to assess myocardial systolic (S) and diastolic (E‚Ä≤, A‚Ä≤) waves of LV and RV. All measurements were usually made in triplicate during different heart cycles, as previously reported. <ref type="bibr" target="#b10">11,</ref><ref type="bibr" target="#b12">13</ref> CT scan</p><p>Forty-three patients with COPD have been recently studied with 6-and 64-detector row CT scanners (Siemens Medical Solutions, Forchheim, Germany). All whole-lung CT scans were acquired during one deep inspiratory breath-hold without the use of any contrast medium. Both scanners were daily calibrated on air to allow reliable measurements and comparison between examinations. Standard 6-detector row CT scanner parameters were as follows: 120 kV, effective 120 mAs, individual detector collimation 1 mm, gantry rotation time of 0.5 second, and pitch 1.25. The 64-detector row CT scanner parameters were as follows: 120 kV, effective 100 mAs, individual detector collimation 0.6 mm, gantry rotation time of 0.5 second, and pitch 1.</p><p>CT images data were reconstructed at 1-mm-thick sections with a reconstruction increment of 1 mm and a sharp kernel (B70f). They were transferred to a personal computer running MevisPULMO software (version 1.4, Fraunhofer MEVIS, Bremen, Germany) and analyzed for quantitative emphysema assessment by one operator (NS). A 3√ó3 kernelbased axial Gauss smoothing was applied to minimize the noise in sharp kernel images. For the whole lung, emphysema extent was defined as percentage of lung voxels #-950 Hounsfield units. <ref type="bibr" target="#b13">14</ref> </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>statistical analysis</head><p>Data are expressed as mean ¬± standard deviation (SD) or median (interquartile range) depending on the normality of data, assessed by using the Kolmogorov-Smirnov test. Consequently, controls and patients with COPD were compared for each variable using parametric or nonparametric univariate statistics (Student's t-test or Mann-Whitney test).</p><p>Pearson correlations were performed to analyze the associations between variables of lung function (such as GOLD class, spirometry data, and emphysema score) and cardiac chamber size.</p><p>Multiple regression analysis was used to analyze the relationship between COPD disease and the echocardiographicbased variables (LVM, RWT, and LV EDD), with age, heart rate (HR), BMI, and systolic BP or pulmonary pressure, respectively, for LV or RV parameters as the covariates. Smoking habits, FEV 1 , and FEV 1 /FVC were not included in the analysis as collinear with the presence of COPD disease (R-values .0.5 and variance inflation factor in multivariate models .2).</p><p>To test if RWT was predictive of the severity of COPD disease in patients with COPD, receiver operating characteristic (ROC) curve was done reporting the area under curve (AUC) value as general diagnostic tool, and the flex point, ie, where the sum of sensitivity and specificity reached a maximum, was used to divide the patients with COPD into two groups.</p><p>Hospitalizations for patients with COPD were considered as 1) overall number of hospitalizations for COPD and/or CV events normalized for observation time, rounding the number as integer in 10 years and 2) time elapsing from the start of the study and the first hospitalization. In the first case, because of the distribution of hospitalization, an overdispersed Poisson regression model was performed. In the second case, a Cox regression model was applied. In both cases, the categorical variable RWT # cutoff point and . cutoff point was used.</p><p>A two-tailed P-value ,0.05 was always considered as significant. SPSS 22.0 (IBM Corporation, Armonk, NY, USA) was used for all the statistical analysis.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Patients' characteristics</head><p>We scrutinized 56 COPD inpatients and outpatients. Seven patients with negative cardiovascular history were excluded during enrollment because of a mild valvular and/or dilative heart disease as detected by echocardiography. A total of 49 patients (45-85 years old) were finally enrolled.</p><p>In 43 patients, CT scans were available. We screened 36 healthy volunteers without previous history of respiratory, cardiovascular, and metabolic disorders as the control group.</p><p>The clinical data of patients with COPD and of their controls are presented in <ref type="table" target="#tab_0">Table 1</ref>. Patients were slightly older than controls, but both groups matched for sex and anthropometric parameters such as BMI and BSA. Systolic and diastolic BPs of the two groups were superimposable, but HR was higher in patients than in controls. Smoking habits and medical history of hypertension were greater in COPD (P,0.001 and P,0.05, respectively). No significant difference was observed in the history of diabetes mellitus <ref type="table" target="#tab_0">(Table 1)</ref>.</p><p>Pulmonary function values are listed in <ref type="table" target="#tab_1">Table 2</ref>. All the GOLD-4 classes were homogenously (21%, 35%, 29%, and 15%) represented. The emphysema score was 18%¬±13% ranging from 1% to 53%. A total of 33 (68%) patients with COPD received inhaled Œ≤2 agonist agents, 26 (53%) received inhaled steroids, and 17 (35%) received inhaled muscarinic antagonists. The majority of hypertensive individuals were treated with a monotherapy of antihypertensive agents, while only six patients with COPD received a combination therapy (four COPD and one control with Œ≤-blockers, 18 COPD and three controls with angiotensin-converting enzyme inhibitors/angiotensin receptor blockers, and five COPD and one control with calcium antagonists).</p><p>During follow-up (42.2 [SD: 20.7] months), seven patients with COPD died and 16 were hospitalized once or more for respiratory or cardiac complications (only two because of cardiovascular events).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>echocardiography</head><p>Patients with COPD, as compared with controls, exhibited a significant decrease of LV chamber size as assessed by EDD and EDV, which was associated with a significant increase in SWT and a mild, nonsignificant increase in PWT. Therefore, RWT was markedly higher in patients, suggesting that concentric remodeling occurs in COPD ( <ref type="table" target="#tab_2">Table 3)</ref>. The absolute and indexed LVM were similar in the two groups as was the percentage of patients with positive ECHO criteria for LVH.</p><p>LV systolic functions, assessed by FS and EF, were similar between the two groups, but stroke volume was lower in COPD versus controls <ref type="table" target="#tab_4">(Table 4</ref>). The mitral inflow pattern showed significant reduction of the E/A ratios in patients with COPD, but no significant differences in systolic and diastolic functions were detected by DTE between the two groups <ref type="table" target="#tab_4">(Table 4)</ref>.    <ref type="table" target="#tab_5">Table 5</ref> reports the results of RV assessment. A mild but nonsignificant increase in ventricular dimensions was observed in patients with COPD. The tricuspidal E-wave and the myocardial E‚Ä≤, E‚Ä≤/A‚Ä≤ ratios and S‚Ä≤-wave, all assessed as time-velocity integral, were reduced, suggesting impairments of both systolic and diastolic functions. Pulmonary pressure estimated by tricuspidal insufficiency was increased, and the acceleration time of pulmonary ejection was reduced in patients with COPD ( <ref type="table" target="#tab_5">Table 5)</ref>.</p><p>After univariate analysis, RWT was strongly correlated with FEV 1 , FEV 1 /FVC, GOLD class, and emphysema scores. EDD and EDV showed significant correlations only with the emphysema score. Finally, SWT correlated with FEV 1 , GOLD class, and CT score but not with FEV 1 /FVC <ref type="table" target="#tab_7">(Table 6</ref>).</p><p>Multiple regression analysis was performed to test the association between LV echocardiographic-derived parameters (RWT, SWT, EDD, and EDV) as outcomes and age, sex, BMI, systolic BP, HR, and the clinical condition (controls or COPD) as predictors ( <ref type="table">Table 7)</ref>. Only RWT was associated with COPD. All echocardiographic variables -but not SWT -were related to HR. Sex, as expected, <ref type="bibr" target="#b14">15</ref> influenced LV structure. No association was found between the RV parameters and COPD.</p><p>ROC curve analysis showed that RWT, with a cutoff point of 0.40, predicted the severity of the disease with an 83% specificity and a 56% sensitivity (AUC =0.69, 95% CI =0.59-0.81). Patients with COPD with RWT .0.40 versus patients with RWT #0.40 (RWT_CAT variable) showed a significant reduction of FEV 1 /FVC (P=0.017) and a significant increase in emphysema score (P=0.033), whereas FEV 1 and residual volume/TLC were not significantly different.</p><p>Univariate statistics showed that RWT was associated with a higher number of hospitalizations (P=0.034   Finally, overall patient survival was not considered in the statistical analysis because only seven patients died during our study.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p>The main finding of our study is that COPD is associated with LV structural changes characterized by a decrease in EDD and EDV as well as an alteration of ventricular geometry, notably concentric remodeling. Other authors who used echocardiographic techniques and nuclear magnetic resonance <ref type="bibr">,5,16</ref> reported the relationship between COPD and decreased LV size, but this is the first report that provides evidence of direct links between pulmonary function, CT score, and LV geometry.</p><p>In our study, patients with COPD had an increased RWT compared with controls; on average, the former showed RWT values .0.42, which was considered as the cutoff point beyond which concentric remodeling was diagnosed. <ref type="bibr" target="#b16">17</ref> In addition, a more severe degree of respiratory disease was associated with a greater increase of concentric remodeling, as indicated by the significant relationship between LV geometry and GOLD class, spirometry parameters, and CT emphysema score. Furthermore, the outcome of a multivariate statistical analysis including LV echocardiographic-derived parameters (RWT, SWT, EDD, and EDV) as dependent variables and age, sex, BMI, BP, HR and the clinical COPD condition as predictors showed that only RWT was independently related to COPD, whereas no relationship was observed with the other echocardiographic parameters.</p><p>Our study does not confirm the LVH in COPD reported by Anderson et al. <ref type="bibr" target="#b5">6</ref> The absolute and indexed LVM was unchanged in our patients as compared with controls. It is noteworthy that our results are in agreement with those previously reported by echocardiography <ref type="bibr" target="#b17">18</ref> with the highly sophisticated technique -nuclear magnetic resonance. <ref type="bibr" target="#b3">4</ref> Differences in the selection criteria may explain these discrepancies. For example, unlike the study by Anderson et al, <ref type="bibr" target="#b5">6</ref> our patients belonged to all GOLD classes. Moreover, our population included only patients with grade 1 hypertension, treated mostly by monotherapy. We excluded hypertensive patients affected by grades 2 and 3 hypertension. A greater systolic BP in COPD versus controls, as demonstrated by the ambulatory and 24-hour monitoring and the number of antihypertensive-per-treated patients with COPD (median =2), has also been reported by Anderson et al. <ref type="bibr" target="#b5">6</ref> In addition, the age differences in our cohort were low (mean difference ~3 years), albeit weakly statistically significant. By contrast, in the study by Anderson et al, <ref type="bibr" target="#b5">6</ref> the COPD group was, on average, 10 years older than the controls. This ~10-year age difference between the two groups may be critical because population studies report that age is a strong determinant of LVM, independent of height, weight, and sex, both in <ref type="table">Table 7</ref> Multiple regression analysis of the predicting relationship of COPD status with the echocardiographic-based variables, ie, rWT, eDV, eDD, and sWT  childhood and in adults. <ref type="bibr" target="#b18">19,</ref><ref type="bibr" target="#b19">20</ref> In turn, the previously observed differences in LVM between COPD and controls could be mainly related to the different ages of the two groups. Although we did not find any difference in LVH between the two groups, our patients with COPD exhibited a significant increase in RWT as compared with controls. This is crucial to stratify cardiovascular risk in the general population, as a concentric LV remodeling (normal LV mass with increased RWT) is a well-known negative prognostic factor. <ref type="bibr" target="#b6">7,</ref><ref type="bibr" target="#b16">17</ref> As previously demonstrated by Barr et al, <ref type="bibr" target="#b15">16</ref> the extent of emphysema on CT scanning was linearly related to cardiac dimensions expressed by EDD and EDV: a greater magnitude of emphysema corresponds to a greater reduction in LV cavity size. Several explanations have been proposed to explain the relationship between COPD and microcardia. First, there is a lower preload in left cardiac chambers mediated by an intrathoracic hypovolemia and a decrease of the pulmonary vascular bed caused by dynamic hyperinflation. <ref type="bibr" target="#b3">4</ref> This mechanism may explain not only the reductions in LV diameters and volumes but also the lower stroke volumes <ref type="bibr" target="#b15">16</ref> and the supposed LV diastolic dysfunction found at the transmitral Doppler analysis. <ref type="bibr" target="#b20">21</ref> Indeed, the inflow pattern is not only an index of ventricular relaxation and compliance, but it is also influenced by others variables such as the preload and the HR. A lower preload can mimic an impaired LV relaxation in normal functioning heart. <ref type="bibr" target="#b21">22</ref> More sophisticated techniques, such as DTE, which analyzes the contraction and relaxation velocities directly on the myocardium, are less influenced by ventricular loads and provide more sensitive indexes of diastolic function. <ref type="bibr" target="#b21">[22]</ref><ref type="bibr" target="#b22">[23]</ref><ref type="bibr" target="#b23">[24]</ref> In our study, the E/A ratio from the mitral inflow pattern was significantly reduced in COPD, but the myocardial S-and E‚Ä≤-waves were preserved, excluding an impairment in the LV systolic and diastolic function.</p><p>A leftward shift of the interventricular septum consequent to the increased right ventricular afterload could cause a decrease in LV cavity size. <ref type="bibr" target="#b20">21,</ref><ref type="bibr" target="#b24">25</ref> However, this premise is not entirely convincing because, in our study, the configuration of this wall did not differ between the two groups, and we did not find any significant RV enlargement despite the significant increase in pulmonary artery pressure. Our findings are in agreement with previous studies 4,5 that found even smaller RV secondary to the hyperinflation and subsequent lower preload to both heart chambers. In addition, patients with COPD had impaired RV systolic and diastolic functions, as demonstrated by the significant reductions of S-and E‚Ä≤-waves, which were significantly related only to pulmonary artery pressure but not to CT score or FEV 1 /FVC. In summary, we report structural and functional cardiac changes in COPD, but only RWT was independently related to the COPD condition (after multivariate analysis).</p><p>To verify if RWT predicted the severity of the disease, we divided the COPD cohort into two groups according to the ROC curves analysis, and we observed that patients with RWT .0.40 were sicker, with more pronounced reduction in FEV 1 /FVC and more increase in CT score. The prognostic role of RWT was also assessed in relation to respiratory and cardiac hospitalizations: only after the univariate statistics, but not after multivariate Poisson analysis, cardiac geometry was significantly related to this event, with age and FEV 1 /FVC being the only strong predictors. These analyses did not show LV geometry as morbidity predictor, confirming the role of age and clinical variables; however, we speculate that, in a larger series of patients, this structural cardiac index may prove a useful marker of hospitalization risk. During the follow-up, seven deaths occurred, but, owing to the limited number of fatal events, overall patient survival was not considered in the statistical analysis. However, the comparisons between survivors and nonsurvivors revealed that RWT was significantly higher (0.52 versus 0.42, P=0.014) in nonsurvivors, suggesting its potential prognostic value as mortality predictor, which has to be confirmed in the future with a greater number of fatal events.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Limitations and strengths</head><p>The first limitation of our study is the limited number of patients. We must emphasize that all enrolled subjects were thoroughly screened and selected for the absence of any significant comorbidities with effects on the structure and heart function. The average age of the two groups (.60 years) is the one in which it is difficult to encounter subjects free of cardiovascular disease, hypertension, or diabetes.</p><p>The strength of the present study is that a single expert investigator recruited and appraised patients and performed all echocardiographies, thus reducing analytical variability.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conclusion</head><p>We demonstrated that significant alterations -typified by a concentric remodeling -exist in the LV geometry of patients with COPD. LV geometry, compared with LVM, is a littleknown marker of cardiovascular risk. Such structural LV modifications are not associated with an increased LVM or with LV systolic and diastolic dysfunctions. RWT appears to be the only cardiac parameter independently related to COPD and could help identify those patients at greatest risk of cardiac complications. Further studies are warranted to The International Journal of COPD is an international, peer-reviewed journal of therapeutics and pharmacology focusing on concise rapid reporting of clinical studies and reviews in COPD. Special focus is given to the pathophysiological processes underlying the disease, intervention programs, patient focused education, and self management protocols.</p><p>This journal is indexed on PubMed Central, MedLine and CAS. The manuscript management system is completely online and includes a very quick and fair peer-review system, which is all easy to use. Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.</p><p>International Journal of COPD 2016:11 ascertain whether LV geometry is related to morbidity and mortality in COPD.</p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>International</head><label></label><figDesc>Journal of COPDPublish your work in this journalSubmit your manuscript here: http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journal</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1</head><label>1</label><figDesc>anthropometric and clinical data</figDesc><table><row><cell>Parameter</cell><cell>COPD</cell><cell>Controls</cell><cell>P-value</cell></row><row><cell></cell><cell>(n=49)</cell><cell>(n=36)</cell><cell></cell></row><row><cell>age (years)</cell><cell cols="3">66.3¬±9.1 62.7¬±6.5 ,0.05</cell></row><row><cell>Male/female (%)</cell><cell>76/24</cell><cell>69/31</cell><cell>ns</cell></row><row><cell>height (cm)</cell><cell>1.7¬±0.1</cell><cell>1.7¬±0.1</cell><cell>ns</cell></row><row><cell>Weight (kg)</cell><cell>72¬±13</cell><cell>75¬±10</cell><cell>ns</cell></row><row><cell>BMI (kg/m 2 )</cell><cell cols="3">25.3¬±4.0 25.8¬±3.0 ns</cell></row><row><cell>Bsa (m 2 )</cell><cell>1.8¬±0.2</cell><cell>1.9¬±0.2</cell><cell>ns</cell></row><row><cell>sBP (mmhg)</cell><cell>132¬±12</cell><cell>131¬±11</cell><cell>ns</cell></row><row><cell>DBP (mmhg)</cell><cell>82¬±8</cell><cell>83¬±5</cell><cell>ns</cell></row><row><cell>hr (beats-per-minute)</cell><cell>77¬±13</cell><cell>67¬±8</cell><cell>,0.001</cell></row><row><cell>smokers (active and non) (%)</cell><cell>90</cell><cell>31</cell><cell>,0.001</cell></row><row><cell cols="2">arterial hypertension history I stage (%) 43</cell><cell>19</cell><cell>,0.05</cell></row><row><cell>Diabetes mellitus (%)</cell><cell>6</cell><cell>0</cell><cell>ns</cell></row><row><cell>no hospitalization (%)</cell><cell cols="2">32/49 (66) 0</cell><cell></cell></row><row><cell>1 hospitalization (%)</cell><cell>8 (16.7)</cell><cell>-</cell><cell></cell></row><row><cell>.1 hospitalization (%)</cell><cell>8 (16.7)</cell><cell>-</cell><cell></cell></row></table><note>Note: Data are mean ¬± standard deviation or percentage. Abbreviations: BMI, body mass index; Bsa, body surface area; DBP, diastolic blood pressure; HR, heart rate; ns, nonsignificant; SBP, systolic blood pressure.</note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 2</head><label>2</label><figDesc>lung functional characteristics</figDesc><table><row><cell>Spirometry and</cell><cell>COPD</cell><cell>Controls</cell><cell>P-value</cell></row><row><cell>pletismography</cell><cell>(n=49)</cell><cell>(n=36)</cell><cell></cell></row><row><cell>FeV 1 (l)</cell><cell>1.6¬±0.8</cell><cell>3.1¬±0.6</cell><cell>,0.0001</cell></row><row><cell>FeV 1 (%)</cell><cell>57¬±25</cell><cell>106¬±13</cell><cell>,0.0001</cell></row><row><cell>FVC (l)</cell><cell>3.0¬±1.0</cell><cell>4.0¬±0.8</cell><cell>,0.0001</cell></row><row><cell>FeV 1 /FVC</cell><cell>49¬±12</cell><cell>75¬±5</cell><cell>,0.0001</cell></row><row><cell>residual volume (l)</cell><cell>3.4¬±1.3</cell><cell>2.9¬±1.0</cell><cell>ns</cell></row><row><cell>residual volume (%)</cell><cell>149¬±55</cell><cell>126¬±46</cell><cell>ns</cell></row><row><cell>TlC (l)</cell><cell>6.9¬±1.5</cell><cell>7.2¬±1.4</cell><cell>ns</cell></row><row><cell>TlC (%)</cell><cell>115¬±23</cell><cell>115¬±20</cell><cell>ns</cell></row><row><cell>rV/TlC</cell><cell>48¬±13</cell><cell>41¬±16</cell><cell>0.05</cell></row></table><note>Note: Data mean ¬± standard deviation or percentage. Abbreviations: FeV 1 , forced expiratory volume in 1 second; FVC, forced vital capacity; ns, nonsignificant; RV, right ventricular; TLC, total lung capacity.</note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Table 3</head><label>3</label><figDesc>Cardiac structural characteristics assessed by echocardiography</figDesc><table><row><cell>LV morphologic</cell><cell>COPD</cell><cell>Controls</cell><cell>P-value</cell></row><row><cell>parameters</cell><cell>(n=49)</cell><cell>(n=36)</cell><cell></cell></row><row><cell>end-diastolic diameter (mm)</cell><cell>45¬±6</cell><cell>48¬±4</cell><cell>,0.01</cell></row><row><cell>end-systolic diameter (mm)</cell><cell>28¬±6</cell><cell>29¬±5</cell><cell>ns</cell></row><row><cell>end-diastolic volume (ml)</cell><cell>90¬±27</cell><cell>101¬±18</cell><cell>,0.05</cell></row><row><cell>end-systolic volume (ml)</cell><cell>29¬±12</cell><cell>32¬±11</cell><cell>ns</cell></row><row><cell>septal thickness (mm)</cell><cell>9.8¬±1.6</cell><cell>9.0¬±1.4</cell><cell>,0.05</cell></row><row><cell>Posterior wall thickness (mm)</cell><cell>9.4¬±1.4</cell><cell>8.9¬±1.9</cell><cell>ns</cell></row><row><cell>rWT</cell><cell>0.44¬±0.09</cell><cell>0.37¬±0.05</cell><cell>,0.001</cell></row><row><cell>lVM (g)</cell><cell>183¬±54</cell><cell>191¬±50</cell><cell>ns</cell></row><row><cell>lVM/Bsa (g/m 2 )</cell><cell>99¬±24</cell><cell>100¬±22</cell><cell>ns</cell></row><row><cell>lV hypertrophy (%)</cell><cell>36</cell><cell>44</cell><cell>ns</cell></row></table><note>Note: Data mean ¬± standard deviation or percentage. Abbreviations: Bsa, body surface area; lV, left ventricular; lVM, left ventricular mass; rWT, relative wall thickness.</note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3"><head></head><label></label><figDesc>). However, in the multivariate Poisson regression model including age, systolic BP, HR, body surface area, and FEV 1 /FVC, we did not detect significant differences, with FEV 1 /FVC (exp[B] =0.87 [0.79-0.95], P=0.003) and age (exp[B] =1.11 [1.01-1.21], P=0.023) being the only significantly different variables.Data from the previous analysis were confirmed when the time between enrollment and first hospitalization was considered. Specifically, in a Cox regression model with the same covariates, age (HR =1.08 [1.00-1.17], P=0.047) and FEV 1 /FVC (HR =0.88 [0.80-0.96], P=0.005) were the only significantly different variables.</figDesc><table /><note></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_4"><head>Table 4</head><label>4</label><figDesc>left ventricular functional characteristics assessed by echocardiography</figDesc><table><row><cell>Parameter</cell><cell>COPD</cell><cell>Controls</cell><cell>P-value</cell></row><row><cell></cell><cell>(n=49)</cell><cell>(n=36)</cell><cell></cell></row><row><cell>Fs (%)</cell><cell>40¬±12</cell><cell>42¬±6</cell><cell>ns</cell></row><row><cell>eF (%)</cell><cell>69¬±6</cell><cell>68¬±7</cell><cell>ns</cell></row><row><cell>sV (ml)</cell><cell>61¬±17</cell><cell>69¬±11</cell><cell>,0.05</cell></row><row><cell>Mitral e pv (cm/s)</cell><cell>53.6¬±13.6</cell><cell>58.3¬±13.2</cell><cell>ns</cell></row><row><cell>Mitral e tvi (cm)</cell><cell>8.8¬±2.6</cell><cell>10.2¬±2.0</cell><cell>,0.05</cell></row><row><cell>Mitral a pv (cm/s)</cell><cell>69.8¬±12.3</cell><cell>67.1¬±11.8</cell><cell>ns</cell></row><row><cell>Mitral a tvi (cm)</cell><cell>8.4¬±1.9</cell><cell>8.4¬±2.5</cell><cell>ns</cell></row><row><cell>Mitral e/a pv (cm/s)</cell><cell>0.8¬±0.2</cell><cell>0.9¬±0.1</cell><cell>ns</cell></row><row><cell>Mitral e/a tvi (cm)</cell><cell>1.1¬±0.3</cell><cell>1.3¬±0.4</cell><cell>,0.01</cell></row><row><cell>DTe s pv (cm/s)</cell><cell>10.7¬±2.2</cell><cell>10.6¬±2.1</cell><cell>ns</cell></row><row><cell>DTe s tvi (cm)</cell><cell>2.1¬±0.8</cell><cell>2.1¬±0.4</cell><cell>ns</cell></row><row><cell>DTe e‚Ä≤ pv (cm/s)</cell><cell>10.0¬±2.6</cell><cell>9.8¬±2.4</cell><cell>ns</cell></row><row><cell>DTe e‚Ä≤ tvi (cm)</cell><cell>1.1¬±0.3</cell><cell>1.1¬±0.4</cell><cell>ns</cell></row><row><cell>DTe a‚Ä≤ pv (cm/s)</cell><cell>13.9¬±3.1</cell><cell>13.9¬±2.6</cell><cell>ns</cell></row><row><cell>DTe a‚Ä≤ tvi (cm)</cell><cell>1.2¬±0.3</cell><cell>1.2¬±0.3</cell><cell>ns</cell></row><row><cell>DTe e‚Ä≤/a‚Ä≤ pv</cell><cell>0.9¬±0.9</cell><cell>0.8¬±0.3</cell><cell>ns</cell></row><row><cell>DTe e‚Ä≤/a‚Ä≤ tvi</cell><cell>0.9¬±0.3</cell><cell>0.9¬±0.4</cell><cell>ns</cell></row></table><note>Notes: Data mean ¬± standard deviation. Values from DTe analysis are the mean of septal and lateral walls. Abbreviations: a‚Ä≤, end-diastolic myocardial wave; DTe, Doppler tissue echocardiography; e‚Ä≤, proto-diastolic myocardial wave; eF, ejection fraction; Fs, fraction of shortening; pv, peak velocity; s, systolic myocardial wave; sV, stroke volume; tvi, time velocity integral.</note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_5"><head>Table 5</head><label>5</label><figDesc>right ventricular characteristics assessed by echocardiography</figDesc><table><row><cell>Right ventricle</cell><cell>COPD</cell><cell>Controls</cell><cell>P-value</cell></row><row><cell></cell><cell>(n=49)</cell><cell>(n=36)</cell><cell></cell></row><row><cell>end-diastolic diameter (mm)</cell><cell>35.2¬±5.2</cell><cell>33.4¬±4.1</cell><cell>ns</cell></row><row><cell>end-systolic diameter (mm)</cell><cell>25.2¬±4.7</cell><cell>24.1¬±3.9</cell><cell>ns</cell></row><row><cell>Trasversal diameter (mm)</cell><cell>36.8¬±6.5</cell><cell>36.3¬±5.1</cell><cell>ns</cell></row><row><cell>longitudinal diameter (mm)</cell><cell>65.7¬±8.7</cell><cell>65.2¬±7.2</cell><cell>ns</cell></row><row><cell>DTe s pv (cm/s)</cell><cell>15.4¬±4.2</cell><cell>16.1¬±4.2</cell><cell>ns</cell></row><row><cell>DTe s tvi (cm)</cell><cell>2.9¬±0.9</cell><cell>3.2¬±0.7</cell><cell>,0.05</cell></row><row><cell>Tricuspid e pv (cm/s)</cell><cell>40.9¬±8.9</cell><cell>40.9¬±8.7</cell><cell>ns</cell></row><row><cell>Tricuspid e tvi (cm)</cell><cell>6.6¬±2.2</cell><cell>7.7¬±2.1</cell><cell>,0.05</cell></row><row><cell>Tricuspid a pv (cm/s)</cell><cell>42.5¬±9.5</cell><cell>40.1¬±7.1</cell><cell>ns</cell></row><row><cell>Tricuspid a tvi (cm)</cell><cell>5.0¬±1.5</cell><cell>5.1¬±1.4</cell><cell>ns</cell></row><row><cell>DTe e‚Ä≤ pv (cm/s)</cell><cell>13.1¬±4.0</cell><cell>14.6¬±3.7</cell><cell>ns</cell></row><row><cell>DTe e‚Ä≤ tvi (cm)</cell><cell>2.1¬±0.8</cell><cell>2.5¬±0.7</cell><cell>0.01</cell></row><row><cell>DTe a‚Ä≤ pv (cm/s)</cell><cell>18.3¬±4.3</cell><cell>18.5¬±4.2</cell><cell>ns</cell></row><row><cell>DTe a‚Ä≤ tvi (cm)</cell><cell>1.9¬±0.5</cell><cell>1.9¬±0.5</cell><cell>ns</cell></row><row><cell>Tricuspid e/a pv</cell><cell>1.0¬±0.2</cell><cell>1.0¬±0.3</cell><cell>ns</cell></row><row><cell>Tricuspid e/a tvi</cell><cell>1.4¬±0.5</cell><cell>1.6¬±0.5</cell><cell>ns</cell></row><row><cell>DTe e‚Ä≤/a‚Ä≤ pv</cell><cell>0.7¬±0.2</cell><cell>0.8¬±0.2</cell><cell>ns</cell></row><row><cell>DTe e‚Ä≤/a‚Ä≤ tvi</cell><cell>1.1¬±0.4</cell><cell>1.3¬±0.3</cell><cell>,0.05</cell></row><row><cell>Pulmonary pressure (mmhg)</cell><cell>30.9¬±8.2</cell><cell>25.8¬±3.4</cell><cell>,0.01</cell></row><row><cell>AT on pulmonary flow (ms)</cell><cell>119¬±29</cell><cell>144¬±22</cell><cell>,0.001</cell></row></table><note>Note: Data are mean ¬± standard deviation. Abbreviations: a‚Ä≤, end-diastolic myocardial wave; aT, acceleration time; DTe, Doppler tissue echocardiography; e‚Ä≤, proto-diastolic myocardial wave; pv, peak velocity; tvi, time velocity integral; s, systolic myocardial wave.</note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_7"><head>Table 6</head><label>6</label><figDesc>Correlations between lung function, CT score, and cardiac chamber size values</figDesc><table><row><cell>Variable</cell><cell>EDD</cell><cell></cell><cell>EDV</cell><cell></cell><cell>RWT</cell><cell></cell><cell>SWT</cell><cell></cell></row><row><cell></cell><cell>r</cell><cell>P-value</cell><cell>r</cell><cell>P-value</cell><cell>r</cell><cell>P-value</cell><cell>r</cell><cell>P-value</cell></row><row><cell>FeV 1</cell><cell>0.10</cell><cell>ns</cell><cell>0.16</cell><cell>ns</cell><cell>-0.35</cell><cell>,0.05</cell><cell>-0.32</cell><cell>,0.05</cell></row><row><cell>FeV 1 /FVC</cell><cell>0.17</cell><cell>ns</cell><cell>0.18</cell><cell>ns</cell><cell>-0.34</cell><cell>,0.05</cell><cell>-0.22</cell><cell>ns</cell></row><row><cell>gOlD class</cell><cell>-0.15</cell><cell>ns</cell><cell>-0.21</cell><cell>ns</cell><cell>0.36</cell><cell>,0.01</cell><cell>0.33</cell><cell>,0.05</cell></row><row><cell>CT score</cell><cell>-0.36</cell><cell>,0.01</cell><cell>-0.28</cell><cell>,0.05</cell><cell>0.41</cell><cell>,0.01</cell><cell>0.28</cell><cell>,0.05</cell></row><row><cell cols="9">Abbreviations: CT, computed tomography; eDD, left ventricular end-diastolic diameter; eDV, left ventricular end-diastolic volume; FeV 1 , forced expiratory volume in</cell></row></table><note></note></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">International Journal of COPD 2016:11 submit your manuscript | www.dovepress.comDovepress Dovepress</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" n="1">second; FVC, forced vital capacity; GOLD, Global Initiative for Chronic Obstructive Lung Disease; ns, nonsignificant; RWT, relative wall thickness; SWT, septal wall thickness. International Journal of COPD 2016:11 submit your manuscript | www.dovepress.com Dovepress Dovepress</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">submit your manuscript | www.dovepress.com Dovepress Dovepress Dovepress</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgment</head><p>The authors would like to acknowledge Dr Francesco Visioli, who critically revised the manuscript.</p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Disclosure</head><p>The authors report no conflicts of interest in this work.</p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J√∏rgen</forename><surname>Vestbo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Suzanne</forename><forename type="middle">S</forename><surname>Hurd</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Alvar</forename><forename type="middle">G</forename><surname>Agust√≠</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Paul</forename><forename type="middle">W</forename><surname>Jones</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Claus</forename><surname>Vogelmeier</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Antonio</forename><surname>Anzueto</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Peter</forename><forename type="middle">J</forename><surname>Barnes</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Leonardo</forename><forename type="middle">M</forename><surname>Fabbri</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Fernando</forename><forename type="middle">J</forename><surname>Martinez</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Masaharu</forename><surname>Nishimura</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Robert</forename><forename type="middle">A</forename><surname>Stockley</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Don</forename><forename type="middle">D</forename><surname>Sin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Roberto</forename><surname>Rodriguez-Roisin</surname></persName>
		</author>
		<idno type="DOI">10.1164/rccm.201204-0596pp</idno>
		<idno type="PMID">22878278</idno>
		<ptr type="open-access" target="http://ajrccm.atsjournals.org/content/187/4/347.full.pdf+html" />
	</analytic>
	<monogr>
		<title level="j">American Journal of Respiratory and Critical Care Medicine</title>
		<title level="j" type="abbrev">Am J Respir Crit Care Med</title>
		<idno type="ISSN">1073-449X</idno>
		<idno type="ISSNe">1535-4970</idno>
		<imprint>
			<biblScope unit="volume">187</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="347" to="365" />
			<date type="published" when="2013-02-15" />
			<publisher>American Thoracic Society</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">D</forename><surname>Sin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">F</forename><surname>Man</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Chest</title>
		<imprint>
			<biblScope unit="volume">127</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="1952" to="1959" />
			<date type="published" when="2005" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Cardiovascular Injury and Repair in Chronic Obstructive Pulmonary Disease</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><surname>Macnee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Maclay</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Mcallister</surname></persName>
		</author>
		<idno type="DOI">10.1513/pats.200807-071th</idno>
		<idno type="PMID">19017737</idno>
		<idno type="PMCID">PMC2643206</idno>
		<ptr type="open-access" target="http://europepmc.org/articles/pmc2643206?pdf=render" />
	</analytic>
	<monogr>
		<title level="j">Proceedings of the American Thoracic Society</title>
		<title level="j" type="abbrev">Proceedings of the American Thoracic Society</title>
		<idno type="ISSN">1546-3222</idno>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="824" to="833" />
			<date type="published" when="2008-12-01" />
			<publisher>American Thoracic Society</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Reduced Intrathoracic Blood Volume and Left and Right Ventricular Dimensions in Patients With Severe Emphysema</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kirsten</forename><surname>J√∂rgensen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Markus</forename><forename type="middle">F</forename><surname>M√ºller</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jacqueline</forename><surname>Nel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Richard</forename><forename type="middle">N</forename><surname>Upton</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Erik</forename><surname>Houltz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sven-Erik</forename><surname>Ricksten</surname></persName>
		</author>
		<idno type="DOI">10.1378/chest.06-2245</idno>
		<idno type="PMID">17426209</idno>
	</analytic>
	<monogr>
		<title level="j">Chest</title>
		<title level="j" type="abbrev">Chest</title>
		<idno type="ISSN">0012-3692</idno>
		<imprint>
			<biblScope unit="volume">131</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="1050" to="1057" />
			<date type="published" when="2007-04" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Decreasing Cardiac Chamber Sizes and Associated Heart Dysfunction in COPD</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Henrik</forename><surname>Watz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Benjamin</forename><surname>Waschki</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Trhorsten</forename><surname>Meyer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gunther</forename><surname>Kretschmar</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Anne</forename><surname>Kirsten</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Martin</forename><surname>Claussen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Helgo</forename><surname>Magnussen</surname></persName>
		</author>
		<idno type="DOI">10.1378/chest.09-2810</idno>
		<idno type="PMID">20190002</idno>
	</analytic>
	<monogr>
		<title level="j">Chest</title>
		<title level="j" type="abbrev">Chest</title>
		<idno type="ISSN">0012-3692</idno>
		<imprint>
			<biblScope unit="volume">138</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="32" to="38" />
			<date type="published" when="2010-07" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Left Ventricular Hypertrophy in COPD Without Hypoxemia</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">William</forename><forename type="middle">J</forename><surname>Anderson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Brian</forename><forename type="middle">J</forename><surname>Lipworth</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sushma</forename><surname>Rekhraj</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Allan</forename><forename type="middle">D</forename><surname>Struthers</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jacob</forename><surname>George</surname></persName>
		</author>
		<idno type="DOI">10.1378/chest.12-0775</idno>
		<idno type="PMID">22797769</idno>
	</analytic>
	<monogr>
		<title level="j">Chest</title>
		<title level="j" type="abbrev">Chest</title>
		<idno type="ISSN">0012-3692</idno>
		<imprint>
			<biblScope unit="volume">143</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="91" to="97" />
			<date type="published" when="2013-01" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Prognostic Implications of Echocardiographically Determined Left Ventricular Mass in the Framingham Heart Study</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Daniel</forename><surname>Levy</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Robert</forename><forename type="middle">J</forename><surname>Garrison</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Daniel</forename><forename type="middle">D</forename><surname>Savage</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">William</forename><forename type="middle">B</forename><surname>Kannel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">William</forename><forename type="middle">P</forename><surname>Castelli</surname></persName>
		</author>
		<idno type="DOI">10.1056/nejm199005313222203</idno>
		<idno type="PMID">2139921</idno>
	</analytic>
	<monogr>
		<title level="j">New England Journal of Medicine</title>
		<title level="j" type="abbrev">N Engl J Med</title>
		<idno type="ISSN">0028-4793</idno>
		<idno type="ISSNe">1533-4406</idno>
		<imprint>
			<biblScope unit="volume">322</biblScope>
			<biblScope unit="issue">22</biblScope>
			<biblScope unit="page" from="1561" to="1566" />
			<date type="published" when="1990-05-31" />
			<publisher>New England Journal of Medicine (NEJM/MMS)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Relation of Left Ventricular Mass and Geometry to Morbidity and Mortality in Uncomplicated Essential Hypertension</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Michael</forename><forename type="middle">J</forename><surname>Koren</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">B</forename><surname>Devereux</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">N</forename><surname>Casale</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">D</forename><surname>Savage</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">H</forename><surname>Laragh</surname></persName>
		</author>
		<idno type="DOI">10.7326/0003-4819-114-5-345</idno>
		<idno type="PMID">1825164</idno>
	</analytic>
	<monogr>
		<title level="j">Annals of Internal Medicine</title>
		<title level="j" type="abbrev">Ann Intern Med</title>
		<idno type="ISSN">0003-4819</idno>
		<imprint>
			<biblScope unit="volume">114</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page">345</biblScope>
			<date type="published" when="1991-03-01" />
			<publisher>American College of Physicians</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC)</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Giuseppe</forename><surname>Mancia</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Robert</forename><surname>Fagard</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Krzysztof</forename><surname>Narkiewicz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Josep</forename><surname>Red√°n</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Alberto</forename><surname>Zanchetti</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Michael</forename><surname>B√∂hm</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Thierry</forename><surname>Christiaens</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Renata</forename><surname>Cifkova</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Guy</forename><surname>De Backer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Anna</forename><surname>Dominiczak</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Maurizio</forename><surname>Galderisi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Diederick</forename><forename type="middle">E</forename><surname>Grobbee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tiny</forename><surname>Jaarsma</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Paulus</forename><surname>Kirchof</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sverre</forename><forename type="middle">E</forename><surname>Kjeldsen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">St√©phane</forename><surname>Laurent</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Athanasios</forename><forename type="middle">J</forename><surname>Manolis</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Peter</forename><forename type="middle">M</forename><surname>Nilsson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Luis</forename><forename type="middle">Miguel</forename><surname>Ruilope</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Roland</forename><forename type="middle">E</forename><surname>Schmieder</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Per</forename><forename type="middle">Anton</forename><surname>Sirnes</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Peter</forename><surname>Sleight</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Margus</forename><surname>Viigimaa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Bernard</forename><surname>Waeber</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Faiez</forename><surname>Zannad</surname></persName>
		</author>
		<idno type="DOI">10.1097/hjh.0b013e328364ca4c</idno>
		<idno type="PMID">24107724</idno>
		<ptr type="open-access" target="http://eprints.gla.ac.uk/173246/1/173246.pdf" />
	</analytic>
	<monogr>
		<title level="j">Journal of Hypertension</title>
		<title level="j" type="abbrev">Journal of Hypertension</title>
		<idno type="ISSN">0263-6352</idno>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="1925" to="1938" />
			<date type="published" when="2013-10" />
			<publisher>Ovid Technologies (Wolters Kluwer Health)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method.</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">B</forename><surname>Devereux</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>Reichek</surname></persName>
		</author>
		<idno type="DOI">10.1161/01.cir.55.4.613</idno>
		<idno type="PMID">138494</idno>
		<ptr type="open-access" target="https://www.ahajournals.org/doi/pdf/10.1161/01.CIR.55.4.613" />
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<title level="j" type="abbrev">Circulation</title>
		<idno type="ISSN">0009-7322</idno>
		<idno type="ISSNe">1524-4539</idno>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="613" to="618" />
			<date type="published" when="1977-04" />
			<publisher>Ovid Technologies (Wolters Kluwer Health)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Left and right ventricular adaptation assessed by doppler tissue echocardiography in athletes</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Giovanna</forename><surname>Pel√†</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Giacomo</forename><surname>Bruschi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Luca</forename><surname>Montagna</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Massimo</forename><surname>Manara</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Carlo</forename><surname>Manca</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.echo.2003.12.004</idno>
		<idno type="PMID">14981416</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of the American Society of Echocardiography</title>
		<title level="j" type="abbrev">Journal of the American Society of Echocardiography</title>
		<idno type="ISSN">0894-7317</idno>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="205" to="211" />
			<date type="published" when="2004-03" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Roberto</forename><forename type="middle">M</forename><surname>Lang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Luigi</forename><forename type="middle">P</forename><surname>Badano</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Victor</forename><surname>Mor-Avi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jonathan</forename><surname>Afilalo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Anderson</forename><surname>Armstrong</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Laura</forename><surname>Ernande</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Frank</forename><forename type="middle">A</forename><surname>Flachskampf</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Elyse</forename><surname>Foster</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Steven</forename><forename type="middle">A</forename><surname>Goldstein</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tatiana</forename><surname>Kuznetsova</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Patrizio</forename><surname>Lancellotti</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Denisa</forename><surname>Muraru</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Michael</forename><forename type="middle">H</forename><surname>Picard</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ernst</forename><forename type="middle">R</forename><surname>Rietzschel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lawrence</forename><surname>Rudski</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kirk</forename><forename type="middle">T</forename><surname>Spencer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Wendy</forename><surname>Tsang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jens-Uwe</forename><surname>Voigt</surname></persName>
		</author>
		<idno type="DOI">10.1093/ehjci/jev014</idno>
		<idno type="PMID">25712077</idno>
		<ptr type="open-access" target="https://academic.oup.com/ehjcimaging/article-pdf/16/3/233/16851324/jev014.pdf" />
	</analytic>
	<monogr>
		<title level="j">European Heart Journal ‚Äì Cardiovascular Imaging</title>
		<title level="j" type="abbrev">Eur Heart J Cardiovasc Imaging</title>
		<idno type="ISSN">2047-2404</idno>
		<idno type="ISSNe">2047-2412</idno>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="233" to="271" />
			<date type="published" when="2015-02-23" />
			<publisher>Oxford University Press (OUP)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Cardiac Involvement in the Churg-Strauss Syndrome</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Giovanna</forename><surname>Pel√†</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Giovanni</forename><surname>Tirabassi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Paolo</forename><surname>Pattoneri</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Laura</forename><surname>Pavone</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Giovanni</forename><surname>Garini</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Giacomo</forename><surname>Bruschi</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.amjcard.2005.11.088</idno>
		<idno type="PMID">16679097</idno>
	</analytic>
	<monogr>
		<title level="j">The American Journal of Cardiology</title>
		<title level="j" type="abbrev">The American Journal of Cardiology</title>
		<idno type="ISSN">0002-9149</idno>
		<imprint>
			<biblScope unit="volume">97</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="1519" to="1524" />
			<date type="published" when="2006-05" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Comparison of computed density and macroscopic morphometry in pulmonary emphysema.</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">A</forename><surname>Gevenois</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">V</forename><surname>De Maertelaer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>De Vuyst</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Zanen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">C</forename><surname>Yernault</surname></persName>
		</author>
		<idno type="DOI">10.1164/ajrccm.152.2.7633722</idno>
		<idno type="PMID">7633722</idno>
	</analytic>
	<monogr>
		<title level="j">American Journal of Respiratory and Critical Care Medicine</title>
		<title level="j" type="abbrev">Am J Respir Crit Care Med</title>
		<idno type="ISSN">1073-449X</idno>
		<idno type="ISSNe">1535-4970</idno>
		<imprint>
			<biblScope unit="volume">152</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="653" to="657" />
			<date type="published" when="1995-08" />
			<publisher>American Thoracic Society</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Sex-related differences in left ventricular structure in early adolescent non-professional athletes</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Giovanna</forename><surname>Pel√†</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Antonio</forename><surname>Crocamo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mauro</forename><surname>Li Calzi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Marina</forename><surname>Gianfreda</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Margherita</forename><forename type="middle">I</forename><surname>Gioia</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Francesco</forename><surname>Visioli</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Paolo</forename><surname>Pattoneri</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Domenico</forename><surname>Corradi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Matteo</forename><surname>Goldoni</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Alberto</forename><surname>Montanari</surname></persName>
		</author>
		<idno type="DOI">10.1177/2047487315608826</idno>
		<idno type="PMID">26405258</idno>
	</analytic>
	<monogr>
		<title level="j">European Journal of Preventive Cardiology</title>
		<title level="j" type="abbrev">Eur J Prev Cardiolog</title>
		<idno type="ISSN">2047-4873</idno>
		<idno type="ISSNe">2047-4881</idno>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="777" to="784" />
			<date type="published" when="2015-09-24" />
			<publisher>SAGE Publications</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Percent Emphysema, Airflow Obstruction, and Impaired Left Ventricular Filling</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">Graham</forename><surname>Barr</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">David</forename><forename type="middle">A</forename><surname>Bluemke</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Firas</forename><forename type="middle">S</forename><surname>Ahmed</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">Jeffery</forename><surname>Carr</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Paul</forename><forename type="middle">L</forename><surname>Enright</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Eric</forename><forename type="middle">A</forename><surname>Hoffman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Rui</forename><surname>Jiang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Steven</forename><forename type="middle">M</forename><surname>Kawut</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Richard</forename><forename type="middle">A</forename><surname>Kronmal</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jo√£o</forename><forename type="middle">A C</forename><surname>Lima</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Eyal</forename><surname>Shahar</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lewis</forename><forename type="middle">J</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Karol</forename><forename type="middle">E</forename><surname>Watson</surname></persName>
		</author>
		<idno type="DOI">10.1056/nejmoa0808836</idno>
		<idno type="PMID">20089972</idno>
		<idno type="PMCID">PMC2887729</idno>
		<ptr type="open-access" target="http://europepmc.org/articles/pmc2887729?pdf=render" />
	</analytic>
	<monogr>
		<title level="j">New England Journal of Medicine</title>
		<title level="j" type="abbrev">N Engl J Med</title>
		<idno type="ISSN">0028-4793</idno>
		<idno type="ISSNe">1533-4406</idno>
		<imprint>
			<biblScope unit="volume">362</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="217" to="227" />
			<date type="published" when="2010-01-21" />
			<publisher>New England Journal of Medicine (NEJM/MMS)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">The Progression of Hypertensive Heart Disease</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">H</forename><surname>Drazner</surname></persName>
		</author>
		<idno type="DOI">10.1161/circulationaha.108.845792</idno>
		<idno type="PMID">21263005</idno>
		<ptr type="open-access" target="https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.108.845792" />
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<title level="j" type="abbrev">Circulation</title>
		<idno type="ISSN">0009-7322</idno>
		<idno type="ISSNe">1524-4539</idno>
		<imprint>
			<biblScope unit="volume">123</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="327" to="334" />
			<date type="published" when="2011-01-24" />
			<publisher>Ovid Technologies (Wolters Kluwer Health)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Sub-clinical left and right ventricular dysfunction in patients with COPD</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ramsey</forename><surname>Sabit</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Charlotte</forename><forename type="middle">E</forename><surname>Bolton</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Alan</forename><forename type="middle">G</forename><surname>Fraser</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Julie</forename><forename type="middle">M</forename><surname>Edwards</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Peter</forename><forename type="middle">H</forename><surname>Edwards</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Alina</forename><forename type="middle">A</forename><surname>Ionescu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">John</forename><forename type="middle">R</forename><surname>Cockcroft</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Dennis</forename><forename type="middle">J</forename><surname>Shale</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.rmed.2010.01.020</idno>
		<idno type="PMID">20185285</idno>
	</analytic>
	<monogr>
		<title level="j">Respiratory Medicine</title>
		<title level="j" type="abbrev">Respiratory Medicine</title>
		<idno type="ISSN">0954-6111</idno>
		<imprint>
			<biblScope unit="volume">104</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="1171" to="1178" />
			<date type="published" when="2010-08" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Gender Differences in Left Ventricular Growth</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Giovanni</forename><surname>De Simone</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Richard</forename><forename type="middle">B</forename><surname>Devereux</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Stephen</forename><forename type="middle">R</forename><surname>Daniels</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Richard</forename><forename type="middle">A</forename><surname>Meyer</surname></persName>
		</author>
		<idno type="DOI">10.1161/01.hyp.26.6.979</idno>
		<idno type="PMID">7490158</idno>
	</analytic>
	<monogr>
		<title level="j">Hypertension</title>
		<title level="j" type="abbrev">Hypertension</title>
		<idno type="ISSN">0194-911X</idno>
		<idno type="ISSNe">1524-4563</idno>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="979" to="983" />
			<date type="published" when="1995-12" />
			<publisher>Ovid Technologies (Wolters Kluwer Health)</publisher>
		</imprint>
	</monogr>
	<note>Pt 1</note>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Interaction Between Body Size and Cardiac Workload : Influence on Left Ventricular Mass During Body Growth and Adulthood</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>De Simone</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">B</forename><surname>Devereux</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><forename type="middle">R</forename><surname>Kimball</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><forename type="middle">F</forename><surname>Mureddu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">J</forename><surname>Roman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Contaldo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">R</forename><surname>Daniels</surname></persName>
		</author>
		<idno type="DOI">10.1161/01.hyp.31.5.1077</idno>
		<idno type="PMID">9576117</idno>
		<ptr type="open-access" target="https://www.ahajournals.org/doi/pdf/10.1161/01.HYP.31.5.1077" />
	</analytic>
	<monogr>
		<title level="j">Hypertension</title>
		<title level="j" type="abbrev">Hypertension</title>
		<idno type="ISSN">0194-911X</idno>
		<idno type="ISSNe">1524-4563</idno>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="1077" to="1082" />
			<date type="published" when="1998-05-01" />
			<publisher>Ovid Technologies (Wolters Kluwer Health)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Left Ventricular Diastolic Dysfunction in Patients With COPD in the Presence and Absence of Elevated Pulmonary Arterial Pressure</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Georg-Christian</forename><surname>Funk</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Irene</forename><surname>Lang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Peter</forename><surname>Schenk</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Arschang</forename><surname>Valipour</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sylvia</forename><surname>Hartl</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Otto</forename><forename type="middle">Chris</forename><surname>Burghuber</surname></persName>
		</author>
		<idno type="DOI">10.1378/chest.07-2685</idno>
		<idno type="PMID">18339780</idno>
	</analytic>
	<monogr>
		<title level="j">Chest</title>
		<title level="j" type="abbrev">Chest</title>
		<idno type="ISSN">0012-3692</idno>
		<imprint>
			<biblScope unit="volume">133</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="1354" to="1359" />
			<date type="published" when="2008-06" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Assessment of Mitral Annulus Velocity by Doppler Tissue Imaging in the Evaluation of Left Ventricular Diastolic Function</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Dae-Won</forename><surname>Sohn</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">In-Ho</forename><surname>Chai</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Dong-Jun</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hee-Chan</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hyo-Soo</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Byung-Hee</forename><surname>Oh</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Myoung-Mook</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Young-Bae</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yun-Shik</forename><surname>Choi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jung-Don</forename><surname>Seo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Young-Woo</forename><surname>Lee</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0735-1097(97)88335-0</idno>
		<idno type="PMID">9247521</idno>
		<idno type="PII">S0735-1097(97)88335-0</idno>
		<idno type="ark">ark:/67375/6H6-TB8935K5-6</idno>
		<idno type="istexId">D03F04715D85486A56C478D5FAA023F5F8E7656C</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of the American College of Cardiology</title>
		<title level="j" type="abbrev">Journal of the American College of Cardiology</title>
		<idno type="ISSN">0735-1097</idno>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="474" to="480" />
			<date type="published" when="1997-08" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Doppler Tissue Imaging: A Noninvasive Technique for Evaluation of Left Ventricular Relaxation and Estimation of Filling Pressures</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sherif</forename><forename type="middle">F</forename><surname>Nagueh</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Katherine</forename><forename type="middle">J</forename><surname>Middleton</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Helen</forename><forename type="middle">A</forename><surname>Kopelen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">William</forename><forename type="middle">A</forename><surname>Zoghbi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Miguel</forename><forename type="middle">A</forename><surname>Qui√±ones</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0735-1097(97)00344-6</idno>
		<idno type="PMID">9362412</idno>
		<idno type="PII">S0735-1097(97)00344-6</idno>
		<idno type="ark">ark:/67375/6H6-QR8K99QF-2</idno>
		<idno type="istexId">EFC7A64864DC3B570D9EFDD856C11315FA6BA828</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of the American College of Cardiology</title>
		<title level="j" type="abbrev">Journal of the American College of Cardiology</title>
		<idno type="ISSN">0735-1097</idno>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="1527" to="1533" />
			<date type="published" when="1997-11" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Doppler Tissue Echocardiography: Myocardial Wall Motion Velocities in Essential Hypertension</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Pel√†</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Bruschi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Cavatorta</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Manca</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Cabassi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Borghetti</surname></persName>
		</author>
		<idno type="DOI">10.1053/euje.2000.0057</idno>
		<idno type="PMID">11882437</idno>
		<ptr type="open-access" target="https://academic.oup.com/ehjcimaging/article-pdf/2/2/108/7002339/2-2-108.pdf" />
	</analytic>
	<monogr>
		<title level="j">European Journal of Echocardiography</title>
		<title level="j" type="abbrev">European Journal of Echocardiography</title>
		<idno type="ISSN">1525-2167</idno>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="108" to="117" />
			<date type="published" when="2001-06" />
			<publisher>Oxford University Press (OUP)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Echo-Doppler Evaluation of Left Ventricular Impairment in Chronic Cor Pulmonale</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Miriam</forename><surname>Schena</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Enrico</forename><surname>Clini</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Donatella</forename><surname>Errera</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Armido</forename><surname>Quadri</surname></persName>
		</author>
		<idno type="DOI">10.1378/chest.109.6.1446</idno>
		<idno type="PMID">8769491</idno>
	</analytic>
	<monogr>
		<title level="j">Chest</title>
		<title level="j" type="abbrev">Chest</title>
		<idno type="ISSN">0012-3692</idno>
		<imprint>
			<biblScope unit="volume">109</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="1446" to="1451" />
			<date type="published" when="1996-06" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
